Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
暂无分享,去创建一个
C. Peschel | T. Decker | F. Schneller | H. Wagner | T. Sparwasser | G. Lipford | T. Tretter | C Peschel | H Wagner | T Decker | F Schneller | T Sparwasser | T Tretter | G B Lipford
[1] P. Cresswell,et al. Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.
[2] E. Kuramoto,et al. Synthetic Oligonucleotides with Particular Base Sequences from the cDNA Encoding Proteins of Mycobacterium bovis BCG Induce Interferons and Activate Natural Killer Cells , 1992, Microbiology and immunology.
[3] Marc C. Jacob,et al. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. , 1998, Blood.
[4] A. Krieg,et al. Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. , 1998, Journal of immunology.
[5] Fraser Dw. Letter: Whooping-cough vaccination. , 1976, British medical journal.
[6] D. Wallach,et al. Aderka, D. et al. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor- or -. Blood 81, 2076−2084 , 1993 .
[7] H. Mellstedt,et al. Downregulation of the CD95 receptor and defect CD40‐mediated signal transduction in B‐chronic lymphocytic leukemia cells , 1998, European journal of haematology.
[8] J. Karras,et al. Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis. , 1997, Cellular immunology.
[9] G. Bishop,et al. CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.
[10] T. Kipps,et al. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal , 1993, The Journal of experimental medicine.
[11] K. Heeg,et al. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock , 1997, European journal of immunology.
[12] J. Gribben,et al. Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro. , 1997, Blood.
[13] M. Hurme,et al. Diminished production of interleukin‐6 in chronic lymphocytic leukaemia (B‐CLL) cells from patients at advanced stages of disease , 1998, British journal of haematology.
[14] P. Lipsky,et al. Activation of human B cells by phosphorothioate oligodeoxynucleotides. , 1996, The Journal of clinical investigation.
[15] M. Mescher,et al. ICAM‐1 and B7‐1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM‐1 , 1999, European journal of immunology.
[16] R. Vabulas,et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells , 1998, European journal of immunology.
[17] J. Gribben,et al. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. , 1996, Blood.
[18] D. Klinman,et al. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. , 1996, Journal of immunology.
[19] G. Weiner,et al. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. , 1997, Blood.
[20] L. Trentin,et al. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. , 1997, Cancer research.
[21] G. Freeman,et al. Role of the CD40 and CD95 (APO‐1/Fas) antigens in the apoptosis of human B‐cell malignancies , 1997, British journal of haematology.
[22] J. Allison,et al. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. , 1993, Science.
[23] L. Rassenti,et al. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. , 1997, Journal of immunology.
[24] G. Weiner,et al. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Banchereau,et al. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. , 1992, Blood.
[26] T. Kipps,et al. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. , 1998, The Journal of clinical investigation.
[27] G. Gaidano,et al. Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. , 1995, Clinical immunology and immunopathology.
[28] S. O'brien,et al. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. , 1995, Blood.
[29] M. Turner,et al. TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES , 1988, The Lancet.
[30] K. Heeg,et al. Bacterial DNA causes septic shock , 1997, Nature.
[31] M. Yellin,et al. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. , 1994, Journal of immunology.
[32] R. Foà,et al. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. , 1990, Blood.
[33] P. Lipsky,et al. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. , 1994, Journal of immunology.
[34] H. Mischak,et al. CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation , 1998, The EMBO journal.
[35] R. V. van Lier,et al. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. , 1995, Blood.
[36] J. Plumas,et al. Malignant B lymphocytes from non‐Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: An important role of co‐stimulatory molecules CD80 (B7‐1) and CD86 (B7‐2) in stimulation by tumor cells , 1995, European journal of immunology.
[37] O. Majdic,et al. Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia. , 1995, Blood.
[38] Adrian Bird,et al. The essentials of DNA methylation , 1992, Cell.
[39] D. Wallach,et al. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta. , 1993, Blood.
[40] J. Ceuppens,et al. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules , 1997, Leukemia.
[41] K. Heeg,et al. DNA activates human immune cells through a CpG sequence‐dependent manner , 1999, Immunology.
[42] A. Krieg,et al. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. , 1998, Journal of immunology.
[43] M. Schuler,et al. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro. , 1998, Cellular immunology.